A Study to Evaluate the Safety and Efficacy of Lenvatinib in Participants With Refractory Differentiated Thyroid Cancer

Condition:   Thyroid Neoplasms
Intervention:   Drug: Lenvatinib
Sponsor:   Eisai Inc.
Recruiting

https://ift.tt/2KvMKCr